The Eli Lilly and Wuxi AppTec-backed oncology drug developer has raised the money from new and existing backers, and will use the cash to boost its product pipeline.

The Alibaba-backed rail network software developer pushed its overall funding near the $130m mark in a round led by Sanno Capital.

The GV-backed market intelligence platform developer has pushed its total funding past $150m in a series E round led by WestCap Group.

Tencent led an $83.9m round for the insurance technology developer, which counts Axel Springer and ProSiebenSat.1 among its earlier investors.

The Minth Group, Zoll Medical and Abiomed-backed medical device developer has raised at least $217m in total after closing additional series D funding.

Intel Capital chipped in as part of a series B round set to drive product development and growth for food supply insights provider Gro Intelligence.

The Sinopharm and WuXi AppTec-backed, complement system-focused drug developer has hauled in $53.3m of new funding after emerging from stealth late last year.

The cardiovascular treatment device developer raised about $46m in a round led by Tencent and has now secured roughly $60m altogether.

Monogenic disease therapy developer Lexeo Therapeutics has publicly launched with financing from backers including Lundbeckfonden Ventures.

The CreditEase and Mouro Capital-backed payment technology provider lured personal finance firm OneMain Financial to co-lead its series C round.